{
    "clinical_study": {
        "@rank": "21526", 
        "acronym": "SOS AOH", 
        "arm_group": [
            {
                "arm_group_label": "1: phone to call center", 
                "arm_group_type": "Experimental", 
                "description": "recommendations to phone to the call center for all the patients who have an acute attack"
            }, 
            {
                "arm_group_label": "2: usual strategy", 
                "arm_group_type": "No Intervention", 
                "description": "usual strategy. No intervention (patients does not change their practice)"
            }
        ], 
        "brief_summary": {
            "textblock": "This clinical trial aims to compare morbidity and cost associated with acute attacks of\n      hereditary angioedema in patients with an intervention based on a support after a phone call\n      to the call center (SOS HAE) from a group of patients does not change their practice."
        }, 
        "brief_title": "A Call Center During HAE Attacks (SOS HAE)", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hereditary Angioedema", 
        "condition_browse": {
            "mesh_term": [
                "Angioedema", 
                "Angioedemas, Hereditary"
            ]
        }, 
        "detailed_description": {
            "textblock": "Investigators propose a study to determine whether a call center for an acute attack of HAE\n      associated with intervention recommendations based on systematic early treatment\n      (self-administration at home or by a caregiver) would reduce the morbidity and the\n      socioeconomic impact."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with an hereditary angioedema followed in a reference center for bradykinin\n             angioedema (CR\u00e9Ak)\n\n          -  Patient's age \u2265 18 years\n\n          -  Consent to the participation in the study\n\n          -  Affiliated to social security\n\n        Exclusion Criteria:\n\n          -  pregnant woman\n\n          -  recent history of myocardial infarction\n\n          -  recent history of stroke\n\n          -  allergy to icatibant or C1 inhibitor concentrate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679912", 
            "org_study_id": "P110109", 
            "secondary_id": "2012-A00044-39"
        }, 
        "intervention": {
            "arm_group_label": "1: phone to call center", 
            "description": "recommendations to phone to the call center for all the patients who have an acute attack", 
            "intervention_name": "phone to the call center", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hereditary angioedema", 
            "Emergency Medical Service", 
            "Health care coast", 
            "Telephone"
        ], 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bobigny", 
                    "country": "France", 
                    "state": "Ile de France", 
                    "zip": "93000"
                }, 
                "name": "SAMU 93 - H\u00f4pital Avicenne"
            }, 
            "investigator": {
                "last_name": "Fr\u00e9d\u00e9ric ADNET, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hereditary Angioedema : Interest From the Use of a Call Center During the Attacks.", 
        "overall_contact": {
            "email": "frederic.adnet@avc.aphp.fr", 
            "last_name": "Fr\u00e9d\u00e9ric ADNET, MD,PhD", 
            "phone": "33 (0)1 48 96 44 08"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique - H\u00f4pitaux de Paris", 
            "last_name": "Fr\u00e9d\u00e9ric ADNET, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of patients hospitalized per year for an observation period of two years [Time Frame : 2 years]", 
            "measure": "Percentage of patients hospitalized per year for an observation period of two years at 2 years", 
            "safety_issue": "Yes", 
            "time_frame": "at 2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679912"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of hospitalizations per year in intensive care unit [Time Frame : 2 years]", 
                "measure": "Number of hospitalizations per year in intensive care unit [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Number of emergency departments visits per year [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Number of hospitalizations [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Number of intubations per year [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Number of interventions of Emergency Medical System [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Number of stop disease and duration [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "measure": "Mortality [Time Frame : 2 years]", 
                "safety_issue": "Yes", 
                "time_frame": "at 2 years"
            }, 
            {
                "description": "total cost : cost of one hospitalization x number of hospitalization", 
                "measure": "Cost of the hospitalization", 
                "safety_issue": "No", 
                "time_frame": "at 2 years"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}